Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HMA
HEALTH MGMT ASSOC INC CL-A
HMA
|
+$105M |
| 2 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$86.2M |
| 3 |
ELN
ELAN CORP ADS(RP1 ORD4IRISH PN
ELN
|
+$78.8M |
| 4 |
Bank of America
BAC
|
+$73.8M |
| 5 |
CTB
Cooper Tire & Rubber Co.
CTB
|
+$64M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$112M |
| 2 |
Zoetis
ZTS
|
+$95.2M |
| 3 |
Ameriprise Financial
AMP
|
+$71.8M |
| 4 |
CLWR
CLEARWIRE CORP NEW CL A COM STK (DE)
CLWR
|
+$67.1M |
| 5 |
Citigroup
C
|
+$65.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.44% |
| 2 | Healthcare | 12.84% |
| 3 | Technology | 12.15% |
| 4 | Consumer Discretionary | 9.87% |
| 5 | Industrials | 8.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PCYC
526
DELISTED
PHARMACYCLICS INC
PCYC
| $9.52M | 0.03% |
68,790
+22,884
| +50% | +$2.54M |
|
527
Tractor Supply
TSCO
$18.4B
| $9.5M | 0.03% |
706,995
-108,525
| -13% | -$1.34M |
|
528
Minerals Technologies
MTX
$2.24B
| $9.43M | 0.03% |
191,052
-25,441
| -12% | -$1.17M |
|
529
PVH
PVH
$3.44B
| $9.41M | 0.03% |
79,323
-14,877
| -16% | -$1.91M |
|
|
PLL
530
DELISTED
PALL CORP
PLL
| $9.36M | 0.03% |
121,504
-8,400
| -6% | -$602K |
|
|
UNT
531
DELISTED
UNIT Corporation
UNT
| $9.35M | 0.03% |
201,061
-23,439
| -10% | -$1.08M |
|
|
CORE
532
DELISTED
Core Mark Holding Co., Inc.
CORE
| $9.34M | 0.03% |
562,156
-33,396
| -6% | -$541K |
|
533
Darling Ingredients
DAR
$9.88B
| $9.31M | 0.03% |
439,787
-115,000
| -21% | -$2.34M |
|
534
Innospec
IOSP
$2.32B
| $9.27M | 0.03% |
198,671
-88,941
| -31% | -$3.83M |
|
535
The GEO Group
GEO
$4.23B
| $9.24M | 0.03% |
416,675
+100,500
| +32% | +$2.25M |
|
536
Polaris
PII
$3.62B
| $9.22M | 0.03% |
71,408
-33,176
| -32% | -$3.73M |
|
537
ICICI Bank
IBN
$109B
| $9.21M | 0.03% |
1,662,029
-3,848,900
| -70% | -$22.6M |
|
|
PRE
538
DELISTED
PARTNERRE LTD
PRE
| $9.18M | 0.03% |
100,236
+9,036
| +10% | +$809K |
|
539
Emergent Biosolutions
EBS
$289M
| $9.18M | 0.03% |
481,636
-40,365
| -8% | -$721K |
|
|
DRC
540
DELISTED
DRESSER-RAND GROUP INC
DRC
| $9.17M | 0.03% |
146,946
-72,320
| -33% | -$4.51M |
|
541
Annaly Capital Management
NLY
$17.4B
| $9.05M | 0.03% |
195,311
+17,975
| +10% | +$846K |
|
|
PTR
542
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $9.02M | 0.03% |
82,076
+4,200
| +5% | +$481K |
|
543
Analog Devices
ADI
$181B
| $9.02M | 0.03% |
191,660
+33,776
| +21% | +$1.62M |
|
544
Lam Research
LRCX
$394B
| $9.01M | 0.03% |
1,760,540
+1,547,010
| +724% | +$7.56M |
|
|
CNW
545
DELISTED
CON-WAY INC.
CNW
| $8.99M | 0.03% |
208,534
-56,123
| -21% | -$2.38M |
|
|
GTIV
546
DELISTED
GENTIVA HEALTH SERVICES INC
GTIV
| $8.98M | 0.03% |
746,002
-325,287
| -30% | -$3.68M |
|
547
Hanover Insurance
THG
$7.91B
| $8.97M | 0.03% |
162,085
+25,792
| +19% | +$1.37M |
|
548
Xcel Energy
XEL
$48.2B
| $8.96M | 0.03% |
324,639
-331,876
| -51% | -$9.49M |
|
549
Qualcomm
QCOM
$169B
| $8.87M | 0.03% |
131,714
-19,355
| -13% | -$1.27M |
|
550
Brown-Forman Class B
BF.B
$12.9B
| $8.79M | 0.03% |
403,378
+41,309
| +11% | +$931K |
|
Similar funds
Cliff Asness's Q3 2013 Portfolio in Review
As of Q3 2013, Cliff Asness held 2,633 positions worth $28.4B, up 0.7% from $28.2B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.
Cliff Asness withdrew a net $3.1B in Q3 2013, closing 162 positions and reducing 1,040 holdings. Its most notable exit was CLEARWIRE CORP NEW CL A COM STK (DE), an estimated $67.1M position sold in full.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Cliff Asness opened a new position in Twenty-First Century Fox, Inc. Class A worth $91.7M.
- Cliff Asness's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 2,736,469 shares worth $91.7M.
- Cliff Asness added most to HEALTH MGMT ASSOC INC CL-A in Q3 2013, an estimated $105M increase.
- Cliff Asness's biggest Q3 2013 reduction was Pfizer, cutting an estimated $112M.
- Cliff Asness fully exited CLEARWIRE CORP NEW CL A COM STK (DE) in Q3 2013, selling an estimated $67.1M.
- Cliff Asness's ten largest holdings make up 8.2% of its $28.4B portfolio in Q3 2013.
- Cliff Asness opened 316 new positions and closed 162 in Q3 2013.
- Cliff Asness's portfolio value rose 0.7% quarter-over-quarter to $28.4B.
Based on AQR Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.